- Home
- Products
Saphnelo (anifrolumab-fnia)
Saphnelo (anifrolumab-fnia)
- Medicine Name: Saphnelo
- Generic Name: Anifrolumab-fnia
- Dosage Form & Strength: Injection – 300 mg/2 mL (150 mg/mL)
- Manufactured By: AstraZeneca Pharmaceuticals LP
Saphnelo is a type I interferon receptor antagonist used to treat adults with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy. It is the first targeted therapy approved for SLE in over a decade and works by reducing inflammation caused by type I interferons, a key contributor to lupus activity.
Recommended Dosage:
- 300 mg administered as an IV infusion over 30 minutes, once every 4 weeks
- Maintain a minimum interval of 14 days between doses
- If a scheduled infusion is missed, administer it as soon as possible
Serious Infections: Saphnelo may increase the risk of infections. Suspend treatment in case of severe or unresponsive infections.
Infusion & Hypersensitivity Reactions: Pre-medicate if the patient has a history of infusion-related issues. Monitor for angioedema, rash, or anaphylaxis.
Risk of Malignancies: Use caution in patients with a history of cancer. Evaluate risks before initiating or continuing therapy.
Vaccine Considerations: Avoid live or live-attenuated vaccines during treatment. Update all immunizations before initiating therapy.
Concomitant Use: Do not combine with other biologics, such as B-cell targeted therapies, unless explicitly recommended.
To legally import Saphnelo to India, the following documents are required:
- A valid prescription from a licensed physician
- Relevant diagnostic reports confirming SLE
- Government-issued patient ID proof
Availability:
Saphnelo is available through Named Patient Import facilitated by Global Rare Meds. We deliver to major cities across India including Mumbai, Delhi, Bangalore, Pune, Chennai, Kolkata, Ahmedabad, and others.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Saphnelo 300 mg/2 mL from certified international suppliers in the USA, Canada, and Europe. Our fulfillment center in Ambernath, Thane District ensures:
- Secure and temperature-controlled packaging
- Validated prescription fulfillment
- Fast dispatch and tracking
- Compliance with all legal import procedures
We ensure 100% authenticity and safety in every shipment.
Q: What is Saphnelo used for?
A: It is used to treat systemic lupus erythematosus (SLE) in adults who are already receiving standard therapy.
Q: What is the generic name of Saphnelo®?
A: Anifrolumab-fnia
Q: Who manufactures Saphnelo®?
A: AstraZeneca Pharmaceuticals LP
Q: Is Saphnelo® approved by the FDA?
A: Yes, it received FDA approval on July 30, 2021.
Q: How is Saphnelo administered?
A: It is given as an intravenous infusion every 4 weeks, under medical supervision.
Q: What are the common side effects of Saphnelo?
A:
- Upper respiratory tract infections
- Infusion-related reactions
- Herpes zoster
- Bronchitis
- Nasopharyngitis
- Cough
Q: Can I take vaccines while on Saphnelo?
A: Avoid live vaccines during treatment. Get all vaccinations updated before starting therapy.
Q: What is the storage guideline for Saphnelo?
A: Store refrigerated at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze or shake.
Q: Is it safe to buy Saphnelo online in India?
A: Yes, through Global Rare Meds, you can legally procure Saphnelo under the Named Patient Program. We ensure authentic sourcing and global delivery.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
